A carregar...
Careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer patients with poor performance status
The retrospective study was conducted to evaluate the efficacy and safety of careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer (aGC) patients with poor performance status (PS = 2 or 3). Patients with aGC of poor PS who had received at least 2 lines o...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6855580/ https://ncbi.nlm.nih.gov/pubmed/31702665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017890 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|